A study on omega-3 transporter protein suggests a potential dietary supplement to prevent non-alcoholic fatty liver disease, emphasizing the protective role of phospholipids against liver fat accumulation. Long-running research by Duke-NUS Medical School into the omega-3 transporter protein Mfsd2
This is a first-of-its-kind international study initiated in 2019 by HistoIndex to examine artificial intelligence (AI)-based approaches that may provide a.